Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Feb;105(2):99-106.
doi: 10.1308/rcsann.2021.0259. Epub 2022 Apr 21.

Is tranexamic acid associated with decreased need for blood transfusion in percutaneous nephrolithotomy: a systematic review and meta-analysis

S Prasad  1 , G Sharma  2 , S Kumar Devana  2 , S Kumar  2 , S Sharma  3
Affiliations
Meta-Analysis

Is tranexamic acid associated with decreased need for blood transfusion in percutaneous nephrolithotomy: a systematic review and meta-analysis

S Prasad et al. Ann R Coll Surg Engl. 2023 Feb.

Abstract

Introduction: Bleeding is a common complication after percutaneous nephrolithotomy (PNL) for renal stone disease. Tranexamic acid (TXA) has been found to reduce mortality and blood transfusion in surgical and trauma patients. This review aimed to assess the safety and efficacy of TXA in patients undergoing PNL.

Methods: A systematic literature review was performed to recognise all randomised controlled trials (RCTs) comparing the use of TXA in PNL. The primary outcome of the study was to compare the need for blood transfusion with and without TXA.

Findings: Six RCTs with 1,323 patients were included in this review. Haemoglobin fall was lower in the TXA group compared with the control group, and the need for blood transfusion was reduced by 67% (odds ratio (OR) 0.33, confidence interval (CI) (0.21, 0.52), p<0.00001). However, blood loss was comparable for the two groups (mean difference -116.9, CI (-244.5,10.7) p=0.07). Length of stay and duration of surgery was significantly shorter with TXA. Furthermore, both minor and major complications were lower in the TXA group. Stone-free rate was higher with the TXA group. No thromboembolic complications were noted in the TXA group.

Conclusions: TXA is safe and efficacious for PNL with a reduction in need for blood transfusion and without an attending increase in complication rates.

Keywords: Meta-analysis; Percutaneous nephrolithotomy; Tranexamic acid.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA-flow chart depicting search strategy used for this review. PRISMA = Preferred Reporting Items for Systematic reviews and Meta-analysis
Figure 2
Figure 2
Risk of bias summary and graph for the studies included in this review
Figure 3
Figure 3
Forest plot comparing TXA group and control group for blood loss, blood transfusion, operative time and haemoglobin fall. TXA = Tranexamic acid
Figure 4
Figure 4
Forest plot comparing TXA group and placebo group for complications, stone-free rate and hospital stay. TXA = Tranexamic acid
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kessaris DN, Bellman GC, Pardalidis NPet al. Management of hemorrhage after percutaneous renal surgery. J Urol 1995; 153: 604–608. - PubMed
    1. Myles PS, Smith JA, Forbes Aet al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 2017; 376: 136–148. - PubMed
    1. de Vasconcellos SJ, de Santana Santos T, Reinheimer DMet al. Topical application of tranexamic acid in anticoagulated patients undergoing minor oral surgery: a systematic review and meta-analysis of randomized clinical trials. J Craniomaxillofac Surg 2017; 45: 20–26. - PubMed
    1. Fillingham YA, Ramkumar DB, Jevsevar DSet al. The efficacy of tranexamic acid in total hip arthroplasty: a network meta-analysis. J Arthroplasty 2018; 33: 3083–3089.e4. - PubMed
    1. Morrison JJ, Dubose JJ, Rasmussen TEet al. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg 2012; 147: 113–119. - PubMed

MeSH terms